Search
for
Sort by
Research 241–270 of 775
- TGFβ and cancer metastasis: an inflammation link
- Immune-Epithelial Cross Talk in Regeneration and Repair
- Lysophospholipid Mediators in Health and Disease
- Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
- Diagnostic, Therapeutic, and Theranostic Multifunctional Microneedles
- CD34 <sup>+</sup> cell–derived fibroblast-macrophage cross-talk drives limb ischemia recovery through the OSM-ANGPTL signaling axis
- Demodicosis in Different Age Groups and Alternative Treatment Options—A Review
- Microneedles as a Promising Technology for Disease Monitoring and Drug Delivery: A Review
- Premature aging syndromes: From patients to mechanism
- Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches
- Intestinal Lymphatic Biology, Drug Delivery, and Therapeutics: Current Status and Future Directions
- Resident macrophages of the lung and liver: The guardians of our tissues
- Cancer-Related Alopecia: From Etiologies to Global Management
- Partial Proteasome Inhibitors Induce Hair Follicle Growth by Stabilizing β-Catenin
- Inhaled Medicines for Targeting Non-Small Cell Lung Cancer
- Drugs linked to blepharitis, meibomian gland dysfunction, and chalazion: a real-world, population-based pharmacovigilance analysis
- Advances of Microneedles for Cancer Diagnosis and Therapy
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Genetic Insights into Acne, Androgenetic Alopecia, and Alopecia Areata: Implications for Mechanisms and Precision Dermatology
- The Impact of Sulforaphane on Sex-Specific Conditions and Hormone Balance: A Comprehensive Review
- DNA Damage, Checkpoint Responses, and Cell Cycle Control in Aging Stem Cells
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- [Translated article] Characteristics, Management, and Prognostic Implications of Adverse Effects of Immune Checkpoint Inhibitors: A Systematic Review
- Alopecia areata as an immune-related adverse event associated with response to immune checkpoint inhibitors
- Embryologic layers in dermatology: Developmental checkpoint disorders, diagnostic insight, and regenerative futures
- Alopecia due to chemotherapeutics, hedgehog inhibitors, targeted antibody therapies and immune checkpoint inhibitors
- IMMUNE-RELATED SKIN TOXICITIES TO CHECKPOINT INHIBITORS THERAPY
- Transposon control as a checkpoint for tissue regeneration
- IMMUNOTHERAPY OF CANCER: IMMUNE CHECKPOINT BLOCKERS, VACCINES AND ADOPTIVE T CELL THERAPIES
- 415 IL-17C: Checkpoint in innate skin immunology